Sunshine Guojian Pharmaceutical
688336----
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Sunshine Guojian Pharmaceutical(688336) the Revenue is 526.78 M (+11.14%);the EBIT is 240.9 M (+14.07%);the EPS is 0.24 (+7.15%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.53B11.14%
----
----
EBIT
0.24B14.07%
----
----
EPS
0.24017.15%
----
----
Upcoming earnings report - Annual FY2026
Available dateMar 26, 2027
Estimate Revenue¥1.67 B
Estimate EBIT¥686.18 M
Estimate EPS¥0.71
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly